Skip to content
Clinical Trial Events
ISPOR Europe 2026

Panel Access and Pricing track

Beware (Non-Proportional) Hazard! Alternative Routes for Dealing with Time-Varying Treatment Effects in Evidence Synthesis for Health Technology Assessment (HTA) Decision Making

Mon, Nov 9, 2026 · 1:45–2:45 PM CET Hall E2, Level 0, Austria Center Vienna

About this session

ISSUE: Often when conducting meta-analyses (MA) of time-to-event (TTE) results, especially in Health Technology Assessment (HTA), a hazard ratio (HR) scale is used due to the ease with which a treatment effect can be incorporated into a cost-effectiveness decision model. However, issues arise when there is evidence of non-proportional hazards in some of the trials/studies included.

Speakers